Pharmacokinetics of Glepaglutide, A Long-Acting Glucagon-Like Peptide-2 Analogue: A Study in Healthy Subjects

BACKGROUND AND OBJECTIVE: Glepaglutide is a novel, long-acting, glucagon-like peptide-2 analogue in a stable aqueous formulation for subcutaneous dosing to treat patients with short bowel syndrome. This study was conducted primarily to characterise the pharmacokinetics of glepaglutide in healthy sub...

Descripción completa

Detalles Bibliográficos
Autores principales: Agersnap, Mikkel Askjær, Sonne, Kim, Knudsen, Kim Mark, Knudsen, Carsten Boye, Berner-Hansen, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705454/
https://www.ncbi.nlm.nih.gov/pubmed/36323988
http://dx.doi.org/10.1007/s40261-022-01210-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705454/
https://www.ncbi.nlm.nih.gov/pubmed/36323988
http://dx.doi.org/10.1007/s40261-022-01210-1

Ejemplares similares